147 related articles for article (PubMed ID: 32133575)
1. Body Mass Index and Age Effects on Brain 11β-Hydroxysteroid Dehydrogenase Type 1: a Positron Emission Tomography Study.
Bini J; Bhatt S; Hillmer AT; Gallezot JD; Nabulsi N; Pracitto R; Labaree D; Kapinos M; Ropchan J; Matuskey D; Sherwin RS; Jastreboff AM; Carson RE; Cosgrove K; Huang Y
Mol Imaging Biol; 2020 Aug; 22(4):1124-1131. PubMed ID: 32133575
[TBL] [Abstract][Full Text] [Related]
2. Imaging the Enzyme 11β-Hydroxysteroid Dehydrogenase Type 1 with PET: Evaluation of the Novel Radiotracer
Gallezot JD; Nabulsi N; Henry S; Pracitto R; Planeta B; Ropchan J; Lin SF; Labaree D; Kapinos M; Shirali A; Lara-Jaime T; Gao H; Matuskey D; Walzer M; Marek GJ; Bellaire S; Yuan N; Carson RE; Huang Y
J Nucl Med; 2019 Aug; 60(8):1140-1146. PubMed ID: 30877174
[TBL] [Abstract][Full Text] [Related]
3. First in-human PET study and kinetic evaluation of [
Bhatt S; Nabulsi NB; Li S; Cai Z; Matuskey D; Bini J; Najafzadeh S; Kapinos M; Ropchan JR; Carson RE; Cosgrove KP; Huang Y; Hillmer AT
J Cereb Blood Flow Metab; 2020 Apr; 40(4):695-704. PubMed ID: 30895878
[TBL] [Abstract][Full Text] [Related]
4. A Novel
Baum E; Zhang W; Li S; Cai Z; Holden D; Huang Y
ACS Chem Neurosci; 2019 May; 10(5):2450-2458. PubMed ID: 30689943
[TBL] [Abstract][Full Text] [Related]
5. Imaging brain cortisol regulation in PTSD with a target for 11β-hydroxysteroid dehydrogenase type 1.
Bhatt S; Hillmer AT; Rusowicz A; Nabulsi N; Matuskey D; Angarita GA; Najafzadeh S; Kapinos M; Southwick SM; Krystal JH; Carson RE; Huang Y; Cosgrove KP
J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34651587
[TBL] [Abstract][Full Text] [Related]
6. Imaging a putative marker of brain cortisol regulation in alcohol use disorder.
Verplaetse TL; Hillmer AT; Bhatt S; Rusowicz A; Li S; Nabulsi N; Matuskey D; Huang Y; McKee SA; Cosgrove KP
Neurobiol Stress; 2024 Mar; 29():100609. PubMed ID: 38304303
[TBL] [Abstract][Full Text] [Related]
7. Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.
Villemagne VL; Doré V; Chong L; Kassiou M; Mulligan R; Feizpour A; Taylor J; Roesner M; Miller T; Rowe CC
J Alzheimers Dis; 2024; 97(3):1463-1475. PubMed ID: 38250767
[TBL] [Abstract][Full Text] [Related]
8. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
Baudrand R; Carvajal CA; Riquelme A; Morales M; Solis N; Pizarro M; Escalona A; Boza C; Pérez G; Domínguez A; Arrese M; Fardella CE
Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
[TBL] [Abstract][Full Text] [Related]
10. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
[TBL] [Abstract][Full Text] [Related]
11. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
[TBL] [Abstract][Full Text] [Related]
12. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
13. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R
Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595
[TBL] [Abstract][Full Text] [Related]
14. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.
Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR
Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326
[TBL] [Abstract][Full Text] [Related]
15. The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer's Disease.
Bini J
J Alzheimers Dis; 2024; 99(1):113-115. PubMed ID: 38607759
[TBL] [Abstract][Full Text] [Related]
16. 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
Valsamakis G; Anwar A; Tomlinson JW; Shackleton CH; McTernan PG; Chetty R; Wood PJ; Banerjee AK; Holder G; Barnett AH; Stewart PM; Kumar S
J Clin Endocrinol Metab; 2004 Sep; 89(9):4755-61. PubMed ID: 15356090
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats.
Sakamuri VP; Ananthathmakula P; Veettil GN; Ayyalasomayajula V
Nutr J; 2011 Jun; 10():70. PubMed ID: 21696642
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
19. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT).
Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M
J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461
[TBL] [Abstract][Full Text] [Related]
20. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
Li X; Lindquist S; Chen R; Myrnäs T; Angsten G; Olsson T; Hernell O
Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
